Call Us Today! 813.461.3336

University of Florida Alpha-1 Research Program

Client Business

The Alpha-1 Research Program at the University of Florida is an international reference laboratory performing full panel analysis for Alpha-1 Antitrypsin Deficiency. The tests consist of Alpha-1 Antitrypsin level, genotype, and phenotype analysis. In cases where a rare variant is detected, Alpha-1 Antitrypsin gene is “melted” and sequenced for variant identification. Currently three Alpha-1 detection programs are utilizing the services of the UF Alpha-1 Antitrypsin Deficiency Detection Laboratory. Through these programs, testing is provided free of charge to the patients.

A1G_2 (2)

Business Challenge

The Alpha-1 group uses a FileMaker solution to track samples and results across three studies of Alpha-1 Antitrypsin Deficiency. The solution is quite complex and requires care when making changes, to ensure accurate processing of samples and reporting of collected data.

Solution Provided

Extensitech is able to provide ongoing support for the existing FileMaker solution, both on-site and via a tightly secured remote connection. Extensitech has helped to streamline various reports, update the change auditing functions, fine-tune the results analysis to reflect new findings, improve and simplify results and add new sample data fields for collection.

Due to HIPPA regulations and medical research compliance, Extensitech is not able to share details of the solution being used by Alpha-1 Groups (A1G).

It is a very complex and robust solution that helps track medical research results, testing, samples, reports, locations, facilities, test subjects, etc. Extensitech’s solution has allowed the researchers at A1G more time to focus on their research as the Extensitech database allows for collecting, reporting, tracking, organizing and finding data in one, user friendly solution.

**Extensitech recently worked with Alpha-1 Group to rebuild their database into FileMaker Pro 13 and implement a bevy of new feature sets for their benefit.


« Previous | Next »